Cargando…
Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
In the present study, various procedures have been compared for the determination of lipophilicity, hydrophobicity, and plasma protein binding of curcuminoids, boswellic acids, andrographolides, and piperine as biologically active ingredients of botanicals used in IBD treatment. Our results have sho...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413514/ https://www.ncbi.nlm.nih.gov/pubmed/36015114 http://dx.doi.org/10.3390/ph15080965 |
_version_ | 1784775770289209344 |
---|---|
author | Jeličić, Mario-Livio Amidžić Klarić, Daniela Kovačić, Jelena Verbanac, Donatella Mornar, Ana |
author_facet | Jeličić, Mario-Livio Amidžić Klarić, Daniela Kovačić, Jelena Verbanac, Donatella Mornar, Ana |
author_sort | Jeličić, Mario-Livio |
collection | PubMed |
description | In the present study, various procedures have been compared for the determination of lipophilicity, hydrophobicity, and plasma protein binding of curcuminoids, boswellic acids, andrographolides, and piperine as biologically active ingredients of botanicals used in IBD treatment. Our results have shown that IAM-HPLC assay is the most suitable one for lipophilicity determination of all analytes regardless of their class and botanical source. HSA-HPAC and AGP-HPAC assays revealed that all investigated compounds have a higher affinity for HSA which is the most abundant protein in human plasma. The high affinity of biologically active compounds to all biological structures (phospholipids and proteins) admonishes that their small portion is available for therapeutic effects in IBD patients. Our experimental research is complemented by various theoretical approaches based on different algorithms for pharmacokinetic properties prediction. The similarities between experimental and calculated values were evaluated using PCA and CA as a statistical tool. The statistical analysis implies that plasma protein binding is a complex process, and theoretical approaches still cannot fully replace experimental ones. |
format | Online Article Text |
id | pubmed-9413514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94135142022-08-27 Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease Jeličić, Mario-Livio Amidžić Klarić, Daniela Kovačić, Jelena Verbanac, Donatella Mornar, Ana Pharmaceuticals (Basel) Article In the present study, various procedures have been compared for the determination of lipophilicity, hydrophobicity, and plasma protein binding of curcuminoids, boswellic acids, andrographolides, and piperine as biologically active ingredients of botanicals used in IBD treatment. Our results have shown that IAM-HPLC assay is the most suitable one for lipophilicity determination of all analytes regardless of their class and botanical source. HSA-HPAC and AGP-HPAC assays revealed that all investigated compounds have a higher affinity for HSA which is the most abundant protein in human plasma. The high affinity of biologically active compounds to all biological structures (phospholipids and proteins) admonishes that their small portion is available for therapeutic effects in IBD patients. Our experimental research is complemented by various theoretical approaches based on different algorithms for pharmacokinetic properties prediction. The similarities between experimental and calculated values were evaluated using PCA and CA as a statistical tool. The statistical analysis implies that plasma protein binding is a complex process, and theoretical approaches still cannot fully replace experimental ones. MDPI 2022-08-04 /pmc/articles/PMC9413514/ /pubmed/36015114 http://dx.doi.org/10.3390/ph15080965 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jeličić, Mario-Livio Amidžić Klarić, Daniela Kovačić, Jelena Verbanac, Donatella Mornar, Ana Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease |
title | Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease |
title_full | Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease |
title_fullStr | Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease |
title_full_unstemmed | Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease |
title_short | Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease |
title_sort | accessing lipophilicity and biomimetic chromatography profile of biologically active ingredients of botanicals used in the treatment of inflammatory bowel disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413514/ https://www.ncbi.nlm.nih.gov/pubmed/36015114 http://dx.doi.org/10.3390/ph15080965 |
work_keys_str_mv | AT jelicicmariolivio accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease AT amidzicklaricdaniela accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease AT kovacicjelena accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease AT verbanacdonatella accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease AT mornarana accessinglipophilicityandbiomimeticchromatographyprofileofbiologicallyactiveingredientsofbotanicalsusedinthetreatmentofinflammatoryboweldisease |